Providing effective care for individuals with prostate cancer is an important issue for oncology nurses. However, the paucity of empirical work regarding the impact of prostate cancer presents a limitation in designing and implementing appropriate nursing interventions. This article presents the findings from a national survey of 621 Canadian men living with prostate cancer regarding the impact of their disease and the availability of support. The most frequently identified problems included sexual function, side effects, fear of dying, incontinence, anger and pain. Approximately one-third of the respondents experienced a lifestyle change, but relatively few indicated experiencing a negative impact from the changes they experienced. The majority of respondents indicated they had been informed accurately about their treatment, but dissatisfaction was expressed regarding lack of information about emotional reactions, alternative therapies, how to speak with other prostate cancer patients and the availability of counselling and self-help groups. Clearly these results have implications for oncology nurses.
Background literature
Prostate cancer often has a protracted natural history of progression. There remains debate regarding the need for aggressive therapy in many patients and no single treatment is universally viewed as effective (Montie, 1994; Talcott, 1996) . Multiple treatment options are available including established ones (i.e., external beam radiation, radical prostatectomy) and investigational ones (i.e., cryosurgery, implant radiation therapy, adjuvant hormonal therapy). Patients with clinically localized prostate cancer may be managed conservatively (watch and wait) or may be given potentially curative treatment in the form of radiotherapy or radical prostatectomy (Smith & Middleton, 1991) . The objective of treatment is to cure the patient and reduce the risk of the disease progressing. With new operative techniques having reduced the complication rate of prostatectomy, this approach is often the treatment of choice for relatively young, otherwise healthy men (Pedersen, Carlsson, Rahmquist & Varenhorst, 1993; Braslis, Santa-Cruz, Brickman & Soloway, 1995) .
In making treatment decisions, the value of halting disease progression is balanced against any unfavourable effects of the intervention. The side effects of treatment (e.g., incontinence, impotence, dysuria, diarrhea) have the potential of influencing an individual's quality of life (Hanks, 1988; Leandri, Rossignol, Gautier & Ramon, 1992) . Some side effects (e.g., nausea, fatigue, incontinence) are relatively short-term and may be more pronounced during the period of treatment delivery (Fossa, 1996) . Others (e.g., impotence, incontinence) may remain for the rest of a man's life (Fowler, Barry, Lu-Yao, Wasson, Roman & Wennberg, 1995) . Changes in lifestyle may be required. Coping with the changes may necessitate access to new types of information and the development of new skills. Cancer and its treatment have the potential to present a myriad of challenges for both patients and their family members.
Interest has increased in recent years regarding outcomes other than survival and disease progression for men diagnosed with prostate cancer. The interest emerged from the recognition that quality of life is an important influence on the choices patients make about treatment and that the viewpoints held by health care professionals and patients about a specific individual's quality of life frequently differ (Da Silva, Reis, Costa & Denis, 1993) . To date, however, relatively little work has focused on determining the influence specific changes resulting from treatment have on quality of life (Kornblith, Herr, Ofman, Scher & Holland, 1994) . Additionally, little work has been completed in documenting prostate cancer patients' perspectives of their experience with illness and treatment. Much of the work to date has focused on performance status and clinical symptoms, without incorporating parameters that reflect the patient's own viewpoint of his condition or what has been found to be helpful.
Two recent studies have attempted to fill this gap. Caffo, Fellin, Graffer & Luciani (1996) included psycho-relational measures in studying 70 patients following radical prostatectomy. They reported that patients adjusted well and the relational aspects of life were affected very little. Patients maintained their relationships with friends (73%) and relatives (83%) and found they did not make fewer trips (69%). The subjective global evaluation of the influence of treatment on social life and life overall was good. Kornblith et al (1994) studied 172 patients of which 55% had received medical and/or surgical hormonal therapy, 28% had received a radical prostatectomy and/or Purpose This current study was undertaken to gather the perspectives of Canadian men about their experiences with prostate cancer, its impact upon them and the help they received in dealing with the impact. It was anticipated this work would provide increased understanding of the various domains in which prostate cancer and its treatment may have an impact and insight regarding strategies for appropriate interventions.
Methods
This study used a descriptive survey approach to provide information about the experiences of Canadian men diagnosed with prostate cancer. The surveys were distributed in two ways. Urologists on the mailing list of two national urology associations, and physicians in selected cancer centres were asked to distribute survey questionnaires to consecutive patients meeting the eligibility criteria over a one-week period. Eligibility criteria included a diagnosis of prostate cancer and ability to read English or French. Forty prostate cancer self-help groups across Canada were requested to distribute the questionnaire at their meetings held during the same time period. Letters were sent to physicians two months later advising them additional surveys could be provided. As a result an additional 110 surveys were distributed, of which 67 were returned.
Questionnaires were completed by the men at home and returned in a stamped, pre-addressed envelope. A total of 965 completed questionnaires from men with prostate cancer were received. Sixty-eight per cent of those were distributed by physicians, 30% by self-help groups and two per cent of unknown source. Based on estimates of the number of questionnaires actually distributed to individual men, the overall response rate was 53%.
Survey instrument development
A survey instrument was designed for this study by the members of the research team. The broad range of topics considered important for inclusion was based on clinical practice and research experience with prostate cancer patients. In particular, previous interview work with members of prostate cancer self-help groups (Gray, Fitch, Davis & Phillips, 1997a) informed the item development.
The survey instrument was pilot tested for clarity and understanding with 10 prostate cancer patients. Minor changes were made to reflect their feedback prior to wide distribution of the questionnaire.
The survey had a total of 52 items which covered the topics of demographics, illness and treatment information, access to information, communication with health care professionals, health system usage, support, impact of illness and treatment, use of unconventional therapies, knowledge about cancer causation and suggestions for public strategies to promote funding for prostate cancer research and care. Although most of the items were close-ended, several provided the opportunity for respondents to write additional details about their experiences.
The focus of this article will be on the detailed results from the items on support, and impact of illness and treatment for those patients who received one type of treatment (i.e., did not receive more than one treatment modality).
Data analysis
For the purposes of this analysis, a subgroup of respondents (n=621) was selected from the total sample (n=965). The subgroup was selected on the basis of having undergone only one treatment for prostate cancer (i.e., external beam radiation, hormonal therapy, prostatectomy, observation). The four treatment groups were analyzed separately. Data analysis consisted of descriptive statistics to calculate the frequency of responses for each close-ended item.
Results

Sample characteristics
In the sample of 621 men, 253 (40.7%) received radiation therapy, 238 (38.3%) underwent surgical removal of the prostate, 84 (13.5%) received hormonal therapy, and 46 (7.4%) were placed on an observation or surveillance plan.
The mean ages for the treatment groups who received radiation therapy, hormonal therapy and observation were similar and above 70 years (see Table One ), while the prostatectomy group had a mean age of 65.8 years. The majority of the respondents were married (84.7%), Caucasian (92.4%) and retired (71.7%). The lowest proportion of retired men was in the prostatectomy group (58.4%). The distribution of household incomes was similar across all treatment groups, with approximately two-thirds having a household income between $20,000 and $79,000. The majority of men (75.5%) were diagnosed between one and five years prior to completing the survey.
Impact of disease and treatment
Frequently identified problems. A list of potential problems was presented in the survey and respondents were asked to indicate which problems had been experienced since diagnosis. Table Two (A) presents the problems identified most frequently by the respondents. In descending order, the problems identified most frequently by the whole group were sexual function (49.8%), side effects (31.6%), fear of dying (28.3%), incontinence (24.0%), anger (13.5%), and pain (11.8%). Sexual function was the most frequently identified problem for the men who had had a prostatectomy (65.5%), those who received hormonal therapy (47.6%) and those who were on surveillance (30.4%). Coping with side effects was the most frequently identified problem for the men in the radiation therapy group (42.7%).
Of those men who had experienced a particular problem since their diagnosis, a proportion indicated they did not feel they had received adequate help with their difficulties. Table Three outlines the proportion of respondents in each treatment group who indicated a negative impact from their cancer and its treatment. Overall, the majority of respondents indicated experiencing either a positive or no impact from their cancer and its treatment. The largest proportion of respondents citing a negative impact indicated the effect was on leisure time (14.7%) and mental health (14.7%). Less than 10% of the respondents cited a negative impact for the remainder of the items.
Availability of support
Communication with others regarding cancer. Table Four outlines the responses from subjects in each treatment group. The majority of respondents (77.5%) indicated they had been informed accurately about the consequences of their treatment (see Table Four ). The highest proportion of those who felt they were accurately informed was observed within the group who had undergone prostate surgery (83.2%).
In the six weeks following diagnosis, 65.1% of the respondents indicated they had a health care professional with whom they could discuss their diagnosis and treatment. Physicians were cited most frequently as the professional with whom the respondents talked. The physicians cited included urologists (85.3%), family physicians (56.4%), oncologists (25.6%), and radiation specialists (18.8%). Nurses were cited by 9.7% of the respondents. Few respondents (2.4%) stated they experienced difficulties talking with health care professionals.
When asked about the desire to talk about their difficulties with cancer, 38.5% of the respondents indicated they had felt the need to talk (see Table Four ). Of these men who cited the need to talk, the majority indicated they had someone with whom they could talk. Family and friends were cited most frequently (35.1%) followed by medical professionals (31.8%) and support groups (26.4%).
The respondents were asked to rate their satisfaction with the various types of information they received. Table Five presents the responses from subjects in each treatment group who were dissatisfied with the information they received. The largest proportion of respondents who indicated they were not satisfied with the information they had received focused on information concerning possible emotional reactions (19%), alternative therapies (18.5%), how to speak to another man with prostate cancer (17.4%), counselling services available (15.3%), and self-help groups (15.1%). The smallest proportion of respondents who indicated dissatisfaction with the information they received was for information about their medical condition (10.1%) and available treatment choices (10.5%). Participation in support groups. A total of 284 (45.7%) of the respondents indicated they had attended or wanted to attend a self-help support group. These respondents indicated several benefits of attending such groups (see Table Six ). Getting more information about prostate cancer and its treatment was cited as a benefit by 62% of these respondents. Other benefits included having the opportunity to find out that others feel the same way (57.7%), having opportunities to help others (50.0%), feeling encouragement and reinforcement (42.2%), hearing about alternative therapies (28.2%) and learning about how to cope with impotence (22.9%).
Helpfulness of others.
Respondents were asked to rate, on a five-point scale, how helpful others had been to them since their diagnosis. Table Seven provides the percentages for each treatment group. More than three-quarters of respondents indicated that family members (80.7%) and physicians (78.3%) had been helpful. Approximately half indicated nurses (54.8%) and friends (53.3%) had been helpful, while other cancer patients (32%), support groups (23.7%), the Canadian Cancer Society (22.1%) and clergy or counsellors (10.3%) were also cited.
Discussion
This nation-wide study was mounted to provide insight regarding Canadian men's experiences being diagnosed and treated for prostate cancer. The findings presented in this article regarding the impact on lifestyle and the availability of support have particular relevance for oncology nurses, especially in the areas of problem identification, patient education and information provision.
The original intent of selecting respondents who had undergone a single treatment was to explore whether there were differences in impact or the availability of support among the treatment groups. With few exceptions, the treatment groups presented very similar profiles. The proportions of respondents reporting changes, difficulties or unmet needs are very similar across the four treatment groups. This implies the planning of nursing care may not have to be entirely specific to the treatment modality.
Clearly, these men experienced problems in both the physical and the psychosocial realms. The proportion of the respondents who experienced problems with sexual functioning and side effects of radiation or surgery is similar to that reported in previous studies. However, the identification of problems regarding anger and fear of dying is new. Of particular interest is the proportion of respondents who did not receive what they thought was adequate help for the problems they experienced. It is unclear from these data whether they did not receive any assistance at all or received assistance that was inadequate. Nevertheless, the finding of unmet need raises several questions of clinical significance. Are the problems men with prostate cancer experience being identified? Are referrals for further assessment and intervention being made when the problems are identified? Are appropriate services available to provide the required assistance? Are the available interventions which are provided found to be unhelpful?
In light of the high prevalence of problems and perceived inadequacy of assistance, it is surprising so few men reported lifestyle change or experienced a negative impact from the disease and its treatment. A high proportion of the men in the sample were retired at the time of their diagnosis. Thus the impact on employment opportunities and work life would be understandably small. The higher negative impact on leisure activities is perhaps more reflective of how their time is spent on a daily basis.
The highest proportion of men indicating a negative impact on mental health was in the observation group. This may reflect difficulties or issues in living with uncertainty and waiting. Men in the other groups have received an intervention aimed to remove the tumour while the men in the observation group continue to live with their tumour and wait to see whether it will change. The challenge in clinical practice is to identify the small proportion of men for whom the impact of their diagnosis is negative and provide effective assistance for them.
Confronting a life-threatening illness is difficult, but it can draw a family closer together, force a re-ordering of priorities and influence a change toward a more healthy lifestyle. These types of changes are frequently perceived as positive and may account for the high proportion of men who indicated a positive impact from their diagnosis and treatment.
Availability of support
The findings concerning communication indicate that many men felt informed about their medical condition and potential consequences of treatment. Many had someone with whom they could discuss the situation. However, the practice issue emerges from the observation that a proportion of the men did not feel informed about the consequences and a proportion did not have anyone with whom they could talk. The challenge is to be able to identify those individuals and provide appropriate assistance to them. Nurses were not identified very often as someone with whom to discuss cancer and its treatment. This could reflect the lack of nursing staff in physicians' offices, short hospital stays, or the roles that nurses have in ambulatory settings. It may also reflect a choice on the part of patients about what topics they talk to certain people about. Given the age of the respondents in this study, many may see the physician as the one to talk with about diagnostic and treatment information. Additionally, some of the men have difficulty talking to female nurses about issues of incontinence, impotence and emotional responses.
It is of interest, however, that many of the topic areas in which patients feel they are not receiving all the information they would like are areas where the potential for nursing input is large. Descriptions about the emotional reactions to a cancer diagnosis, dialogues about alternative therapies, information about the availability of counselling services and self-help groups are all topic areas where nurses could be providing information for men with prostate cancer.
Implications for oncology nurses
Given that nursing interventions ought to include limiting the impact of side effects and assisting the patient to cope with the changes he may be experiencing as a result of the disease and its treatment, there are implications for oncology nurses from this national survey. The clinical implications fall into the arenas of problem identification, information provision and patient education.
Regardless of whether a nurse is in an inpatient or outpatient setting, or interacting with a patient at any point along the 
